RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
@er_td4 Δε νομίζω οτι σας πυροβόλησα. Και γιατί να σας κάνω μπλοκ?? Εδώ είναι η μελέτη (preprint): https://t.co/cxKAewvxOO
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
@NowDev1 @GovInslee @JayInslee @komonews @KING5Seattle @KIRO7Seattle Remdesivir is hardly a cure for COVID. The studies show that it it made little difference in hospitalized patients. https://t.co/RcF4j3HPnt
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
@BirGun_Gazetesi Hiç bir ilacın etkisi kanıtlanmadı zaten https://t.co/2fzjuXVsG1
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
@clumsypops @FinancialTimes HCQ wasn't halted, you clown. It's right here in the WHO trial, and it doesn't work : https://t.co/DAVnKRzF5J
@Doc_B_LE Mein Reden von vor einem Monat 😎 https://t.co/ahyeS6qLmK
RT @cperezd: Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results | medRxiv. Por fin sensatez ....... sobre el uso…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results https://t.co/DdweNi12kN
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 2) and they indeed checked subgroups. and did a meta analysis pooling. Still nothing burger 🍔 for remdesivir. https://t.co/…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
@KonProg @realDonaldTrump Hmmmm very borderline. But not quite significant.
RT @DrEricDing: 10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benef…
10) and the WHO’s Solidarity trial also checked Remdesivir in diff groups: young and old, Low and high risk. No group benefited significantly from it. Nothing.
Sullo stesso tema: ▶️articolo di @cristinamarrone del @Corriere https://t.co/WHSsk6okdP ▶️articolo (preprint) con risultati studio Solidarity dell'OMS (che ha bocciato anche l'idrossiclorochina) https://t.co/NybtbHf85z 2/fine
RT @cperezd: Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results | medRxiv. Por fin sensatez ....... sobre el uso…
RT @cperezd: Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results | medRxiv. Por fin sensatez ....... sobre el uso…
@XIRY2dsqHlACnLh هذا خبر لمقالة نشرت في BMJ تحمل رأي مبني على نتائج دراسة منظمة الصحة العالمية التي بها الكثير من العيوب https://t.co/SPXtK6cQc9
RT @cperezd: Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results | medRxiv. Por fin sensatez ....... sobre el uso…
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results | medRxiv. Por fin sensatez ....... sobre el uso remdesivir. Leer detalladamente https://t.co/IJQ8mnm19Z
@bensaei71 هذا خبر لمقالة نشرت في BMJ تحمل رأي مبني على نتائج دراسة منظمة الصحة العالمية التي بها الكثير من العيوب https://t.co/SPXtK6cQc9
@asmaa_dos محد منعه... اقرو الخبر كامل لا تكتفون بالعنوان هذا خبر لمقالة نشرت في BMJ تحمل رأي مبني على نتائج دراسة منظمة الصحة العالمية التي بها الكثير من العيوب https://t.co/SPXtK6cQc9
Meanwhile... @GteiSemi #solidaritytrial https://t.co/DlXSrsHoVZ
11-19-2020: WHO scientists now advise all nations to stop using remdesivir for COVID-19 https://t.co/DAQHZoyDsD https://t.co/YtrFRh2FbH https://t.co/IUyTSfhF2o https://t.co/ZEMmihAgLz https://t.co/f3He7UUFNx https://t.co/heuEKkzcc3 https://t.co/wO6coPpLIy
@helpuspleas @LillyPad هذا خبر لمقالة نشرت في BMJ تحمل رأي مبني على نتائج دراسة منظمة الصحة العالمية التي بها الكثير من العيوب https://t.co/SPXtK6cQc9
@freedom9230 @Breaking911 Ivermectin is an insecticide. There's absolutely no reason to even test that. Sars-cov2 is a virus, not an insect. And sorry, but that's where we're at : https://t.co/DAVnKRzF5J Nothing really comes out as effective.
@JaburnsLevitas @Breaking911 It doesn't work at all : https://t.co/DAVnKRzF5J And it's incredibly expensive.
@Unite1America @business It doesn't : https://t.co/DAVnKRzF5J
@DrJohnParkes @CovidAnalysis You suck as researcher- cannot find recovery study? https://t.co/BHURYBiKXo let me spoon-feed you baby: Hydroxychloroquine (oral): Hour 0, four tablets; Hour 6, four tablets; Hour 12, begin two tablets twice daily for 10 days.
@ZachariasFoegen @reitschuster Kleiner Hinweis zu Hydroxychloroquin: In "Solidarity" wurde eine deutlich kardiotoxische Dosis (2 g -> 800 mg/d) verwendet. Fachinfo: 200 - 400 mg. https://t.co/6kxK7nQiRJ Anschließend wurden konkurrierende Studien nach e
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
Remdesivir: WHO trial shows no effect https://t.co/7GyubaQpZA European doctors association advises against use https://t.co/56oBFiDwqW and yet EU and NHS make secret deal https://t.co/X63RFKNxyE @sarahboseley Will @NICEComms revise its guidance to the NHS
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
RT @influenzer3: 1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interi…
1) 今回、ESICMが問題にしているSolidarity trialの結果は以下。 まだプレプリントではありますが、そのまま論文になるのでしょう。 Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results https://t.co/D7H48OD6t3
RT @RapidReviewsC19: RR:C19 has published reviews of "Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results" https:…
RR:C19 has published reviews of "Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results" https://t.co/rQX9dDUt2x. To read the reviews, visit: https://t.co/dFmJWwEi5q #COVID19 #SARSCoV2 #worldhealthorganization #antivirals
10/14 DA WAR ABER NOCH WAS bzw. DA KOMMT NOCHWAS: Interimsanalyse des @WHO_Europe_DE @WHO SOLIDARITY TRIAL (https://t.co/Xlc0iqbH2k) + Metaanalyse zu #Remdesivir: https://t.co/iStS9lDMOT
RT @YAYshamsaldeen: @WatanNews ممكن رابط "الدراسات" المحكمة؟ لا تجيب دراسة منظمة الصحة العالمية الضعيفة الخاطئة التي تفتقر للكثير https:/…
RT @YAYshamsaldeen: سلسلة من4 تعليقا على التغريدة المقتبسة بالنظر لمسودة الدراسة في هذا الرابط👇 https://t.co/2xygqoAHwn نجد أن هناك اختل…
@kriptoemre Ne sayılar doğru ne de bedava verilen ilacın faydalı olduğu doğru. O zaman başarı nerede? https://t.co/ixSEp02asX
RT @YAYshamsaldeen: @WatanNews ممكن رابط "الدراسات" المحكمة؟ لا تجيب دراسة منظمة الصحة العالمية الضعيفة الخاطئة التي تفتقر للكثير https:/…
RT @YAYshamsaldeen: @WatanNews ممكن رابط "الدراسات" المحكمة؟ لا تجيب دراسة منظمة الصحة العالمية الضعيفة الخاطئة التي تفتقر للكثير https:/…
@WatanNews ممكن رابط "الدراسات" المحكمة؟ لا تجيب دراسة منظمة الصحة العالمية الضعيفة الخاطئة التي تفتقر للكثير https://t.co/SPXtK6cQc9
@M_TobogganMD @TuurDemeester Given the split between low risk - who saw less deaths on Remdesirvir - and high risk - who saw more deaths - as we get more data it *may* turn out that we just need to optimize who we give it too to get an overall benefit: htt
@M_TobogganMD @TuurDemeester So if I understand this correctly from Figure 4, at the very last page, you're basically talking about the "low/hi-flow" O2 results/"lower risk groups" results? https://t.co/Q3DRlEDv2a Those at least look good. And you're righ
RT @JeremyFarrar: Not the result anyone hoped for. But so important to have robust, definitive data from large randomised trials. Huge cre…
@jan_choutka @MihulkaS @Hospodarky Solidarity studie ukázala fakt prakticky nulovou účinnost https://t.co/e8xZ071Sib
On it goes... https://t.co/ieUPQQVNIG
RT @DrGiovanniD: @DrPacoMoreno1 No entiendo por que querer para nuestro país algo excesivamente caro y sin ningún efecto en mortalidad. htt…
RT @IPFdoc: Summary: 1) Remdesivir no effect. Can it be saved by sub-group analysis? 2) Hydroxychloroqine leaning towards harm. (As expecte…
@amychomd I remain sceptical of a study that shows no survival benefit but shortens length of stay in a subset of patients. I think the WHO SOLIDARITY trial results (pre-print) indicate that benefit is minimal, if it exists at all. See: https://t.co/xopnT
7/10 A meta-analysis of mortality in ACCT-1, SOLIDARITY, Wuhan, SIMPLE studies shows lack of survival benefit for remdesivir, although it almost reaches statistical significance for pts not on a ventilator. Final results of SOLIDARITY are pending. https://
6/10 However, the preliminary results of WHO SOLIDARITY trial casts doubts on the benefits of remdesivir, with no improvement in-hospital mortality, although there was a trend to improved survival in those not on a ventilator. https://t.co/K7hPJ17AJE https
RT @EricTopol: The SOLIDARITY randomized trial of 4 repurposed drugs in 11, 266 hospitalized patients with #COVID19: HCQ, Remdesivir, Inter…
@EspresoTV "незначний" або "не надають жодного" впливу на перебіг хвороби у госпіталізованих і їхнє виживання. Препринт статті опублікований на medRxiv. https://t.co/na9rXB7WKm
RT @DrGiovanniD: @DrPacoMoreno1 No entiendo por que querer para nuestro país algo excesivamente caro y sin ningún efecto en mortalidad. htt…
@DrPacoMoreno1 No entiendo por que querer para nuestro país algo excesivamente caro y sin ningún efecto en mortalidad. https://t.co/qOzoh2wWQC
RT @EndFatigue: A recently released massive World Health Organization (WHO) study showed that in people hospitalized with a virus, the main…
RT @Smackenziekerr: not even the much-touted antiviral drug #remdesivir. Scientists at the World Health Organization (#WHO) released the da…
RT @Smackenziekerr: not even the much-touted antiviral drug #remdesivir. Scientists at the World Health Organization (#WHO) released the da…
not even the much-touted antiviral drug #remdesivir. Scientists at the World Health Organization (#WHO) released the data as a preprint on medRxiv last night, ahead of its planned publication in The New England Journal of Medicine. https://t.co/vUgxbKSe0Y
@worldfflyer @jeremyfaust @A1responder But the World Health Organization last week released interim trial results, which it said would soon be published in a peer-reviewed journal, that showed the drug had "little or no effect in preventing death from COVI
@turki_almutairi تغريدة قديمة... https://t.co/SPXtK6cQc9
RT @Smackenziekerr: The interim results from the #WHO’s Solidarity Therapeutics Trial, said to be the world’s largest randomized control tr…
RT @Smackenziekerr: The interim results from the #WHO’s Solidarity Therapeutics Trial, said to be the world’s largest randomized control tr…
The interim results from the #WHO’s Solidarity Therapeutics Trial, said to be the world’s largest randomized control trial of coronavirus treatments, were published Thursday. https://t.co/Yw2PxTz4qR
RT @PGtzsche1: Remdesivir for coronavius: We were fooled again, just like with Tamiflu for influenza. Doubtful that it works. See article i…
RT @juliomayol: Los resultados de #SOLIDARITY #Covid19 El Hospital Clinico San Carlos ha participado muy activamente en el estudio. Ni l…